Pharmaceutical Companies Face Game-Changing Implications Of Healthcare Reform

NASHVILLE, Tenn., Jan. 29, 2013 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, finds that many of the challenges involved with planning in an uncertain environment can be alleviated with accurate, applicable data and analysis. Sweeping changes in the US healthcare landscape -- such as health insurance exchanges and Medicare Advantage Star Rating metrics -- will alter the ways in which companies participating in the healthcare industry do business. Planning, sales, and marketing teams within pharmaceutical companies are continually calibrating their strategies to incorporate the new developments -- and as the landscape evolves, actionable insight by state becomes a vital tool.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36797LOGO )

"Healthcare will continue to evolve," says Carolyn McMeekin, Principal Director of Managed Markets Analysis at HealthLeaders-InterStudy.  "As the industry gears up for requirements of the Affordable Care Act -- especially the 2014 exchanges, impact of Star Ratings, and the expansion of Medicaid -- it is incumbent upon stakeholders to understand both the big picture and the granularity of the markets in which they do business. We are delighted to have achieved a new, state-by-state, targeted look at these developments that will help pharmaceutical companies easily map their responses to rapidly changing healthcare questions."

As an example, Massachusetts provides an interesting profile -- and one illustrative of how unique each state's specific healthcare situation is.  The impact of national healthcare reform will be felt differently there than in any other state, because Massachusetts has been operating its own exchange since passing a near-universal healthcare law in 2006.

"Massachusetts' healthcare reform law and exchange have been successful in bringing down the number of uninsured, but it has also brought a number of challenges -- as well as some unexpected opportunities," says Ric Gross, Senior Analyst at HealthLeaders-InterStudy. "For instance, with little room for organic growth, insurers have developed new product designs in an attempt to gain membership."

About Health Plan Data & Analysis

NEW: Health Plan Analysis reports are now released on an event-driven schedule, so you can tap into updated data and insights when you most need them.

Health Plan Data & Analysis is the tool for understanding the competitive managed care organization landscape, providing state health plan information that drives meeting preparation, strategic planning, and sales strategy development. It provides insights into the latest state health plan trends that drive local-level sales and planning strategy development and includes updates on:

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources Group company, is the authoritative source for managed care data, analysis, and news. HealthLeaders-InterStudy is part of the Market Access Business Unit at Decision Resources Group which also includes Abacus International, Fingertip Formulary, Pinsonault, and PharmaStrat. Find out more at www.hl-isy.com.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

SOURCE HealthLeaders-InterStudy